Navigation Links
Shane Lyons Joins GenVault Corporation as Vice President of Sales and Marketing
Date:5/4/2009

CARLSBAD, Calif., May 4 /PRNewswire/ -- GenVault Corporation is delighted to welcome Mr. Shane Lyons as Vice President of Sales and Marketing. With over 25 years of experience, Mr. Lyons has achieved an impressive track record of driving sales growth in both the domestic and international life science and clinical marketplaces.

Most recently Mr. Lyons held the position of Vice President of Sales, Americas, for the Protein and Small Molecule Division of Life Technologies (formerly Applied Biosystems, AB), where he managed the sales organization and formulated the strategy for expansion and growth of their Mass Spec business unit. During his time at AB, Mr. Lyons helped lead the Mass Spec business from a number 3 position in the market to the number 1 position. Also during his 10 year tenure at Applied Biosystems, he managed the North America sales organization for all AB businesses including genomics and molecular biology, informatics and mass spectrometry. Before joining AB, Mr. Lyons managed regional sales forces at PerSeptive Biosystems, Abbott Labs, Unipath/Unilever, and Coulter Electronics (Beckman). Mr. Lyons holds a bachelor of science degree in Marketing (minor in Finance) from San Diego State University.

"Shane brings a tremendous depth of commercial experience and knowledge in the life sciences market to GenVault, together with proven sales leadership that has demonstrated significant success in our marketplace," said David Wellis, GenVault's President and CEO. "Shane is a wonderful addition to our senior management team and a real advantage to GenVault."

"I am thrilled at the prospect of joining the GenVault management team at such an important stage of the company's development. With my experience in the market and the growth dynamics and challenges facing the Life Sciences arena today, I believe that GenVault has the products and organization to make a significant impact in the way DNA, blood and RNA is transported, managed and stored for testing and research. I believe these products will make a real impact in the way business is conducted in the future," said Mr. Lyons.

A major focus for Genvault's innovative technology platforms is the risk free transportation and high density storage of samples utilized in biobanking. The falling cost of genomic technologies has expanded the scope of biobanking in the contexts of sample volumes analyzed and the spectrum of research studies that can be addressed. The results of several new diagnostic tests which improve risk assessment and treatment decisions being made in the clinic are based on data derived from biobanks. Analysis of high quality samples from large cohorts derived from biobanks will generate new diagnostic and preventative tools for diseases that will define the future of personalized medicine.

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert: For information on the listed expert, click appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

    Editorial Contact
    Bret Dash, Director of Marketing
    GenVault Corporation
    (760) 268-5242


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 ... Unternehmen für Molekulargenetik, erweitert seine Palette an anpassbaren ... NGS Custom FH Panels, das ein schnelles und ... ermöglicht. Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen ... (CNV) mit einem einzigen kleinen Panel und ermöglicht ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... In response to client demand KbioBox developed a sophisticated “3 click” gene dditing ... are accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by ...
(Date:12/8/2016)... Iowa (PRWEB) , ... December 08, 2016 , ... This ... asynchronous approvals for biotech crops. The authors focus on the economic effects in countries ... global approval of new biotech crops and the resultant risk of low level presence ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
Breaking Biology Technology:
(Date:12/6/2016)... DALLAS , Dec. 6, 2016 ... criminal justice technology solutions for public safety, investigation, ... (PEP) jointly announced today a five (5) year ... exclusive agreement to expand the rehabilitation and reentry ... PEP History Established in 2004, the Prison ...
(Date:12/2/2016)... 2016   SoftServe , a global digital ... an electrocardiogram (ECG) biosensor analysis system for continuous ... asset. The smart system ensures device-to-device communication between ... and mobile devices to easily ,recognize, and monitor ... vehicle technology advances, so too must the security ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
Breaking Biology News(10 mins):